Natural History of Sickle Cell Disease
Part of paid clinical trials in Washington D.C., District of Columbia.
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Study ID
- NCT00081523
- Status
- Recruiting
Conditions
- Pain Crisis
Eligibility Criteria
- Sex
- ALL
- Age
- 2 Years - 90 Years
- Healthy Volunteers
- Not accepted
Study Details
This study is not a treatment protocol and no experimental treatments are involved. Study participants may be seen as needed for clinical, translational and basic research studies, or as medically indicated. Subjects will receive their general medical care outside the NIH and will be seen at our clinic or at CNHS with varying frequency. Subjects may be seen for multiple visits. Subjects may be asked to return for additional testing as needed. Clinical care for patients with sickle cell disease will be provided as appropriate through the Sickle Cell Clinic and the inpatient clinical center.
Key Dates
- Start date
- Apr 29, 2004
- Status verified
- Jun 2026
Study Design
- Enrollment
- 3,500 participants (estimated)
Arms
- Arm: PatientsIndividuals with known or suspected sickle cell disease
Primary Outcome Measure
To gather, through clinical experience, information regarding the natural history, co-morbid conditions and outcomes, and complications relating to sickle cell disease and other hemolytic disorders in minority/ethnic patients [ Time Frame: ongoing ]
Central Contacts
- Nancy A Asomaning(301) 605-0398
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Childrens National Health Center | Washington D.C. | District of Columbia | 20010 | |
| National Institutes of Health Clinical Center | Bethesda | Maryland | 20892 | For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) 800-411-1222 |
| Suburban Hospital | Bethesda | Maryland | 20814 | - |